The role of inflammation in early and late venous thrombosis: Are there clinical implications?

Venous thrombosis is associated with a significant inflammatory response. Inflammatory cells, adhesion molecules (especially selectins), cytokines, and procoagulant microparticles appear to be associated with the thrombogenic process. Once thrombus forms, inflammatory cells are important to thrombus resolution along with fibrinolytic agents and proinflammatory mediators. Collagen and elastin breakdown by the DVT renders the vein wall stiff and non-compliant. Rapid and complete thrombus resolution should lessen vein wall damage and lessen or prevent the development of chronic venous insufficiency. Understanding the basic biology of thrombogenesis and thrombus resolution is important, as novel therapies to both prevent and treat venous thrombosis and hasten thrombus resolution should result from a better understanding of the basic biological mechanisms.

[1]  A. Schmaier,et al.  D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis , 2004, Thrombosis and Haemostasis.

[2]  M. Pfeffer,et al.  C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.

[3]  L. Jørgensen,et al.  Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome , 2005, Thrombosis and Haemostasis.

[4]  A. Kastrati,et al.  Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction , 2004, Thrombosis and Haemostasis.

[5]  T. Wakefield,et al.  Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. , 2005, Blood.

[6]  A. Schmaier,et al.  D-Dimer, P-Selectin, and Microparticles: Novel Markers To Predict Deep Venous Thrombosis. , 2004 .

[7]  T. Wakefield,et al.  Deep vein thrombosis resolution is not accelerated with increased neovascularization. , 2004, Journal of vascular surgery.

[8]  E. Papalambros,et al.  P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment. , 2004, Journal of the American College of Surgeons.

[9]  P. Prandoni Toward the Simplification of Antithrombotic Treatment of Venous Thromboembolism , 2004, Annals of Internal Medicine.

[10]  T. Wakefield,et al.  Deep Vein Thrombosis Resolution Is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A. Mansfield,et al.  Venous Claudication in Iliofemoral Thrombosis: Long-term Effects on Venous Hemodynamics, Clinical Status, and Quality of Life , 2004 .

[12]  H. Messmore,et al.  Mechanisms of Venous and Arterial Thrombosis in Heparin-Induced Thrombocytopenia , 2000, Journal of Thrombosis and Thrombolysis.

[13]  M. Prins,et al.  Fixed dose subcutaneous low molecular weight heparins versus adjusted dose infractionated heparin for venous thromboembolism [Cochrane review] , 2004 .

[14]  J. Caprini,et al.  A Guide to Venous Thromboembolism Risk Factor Assessment , 2004, Journal of Thrombosis and Thrombolysis.

[15]  C. Hack,et al.  Human cell‐derived microparticles promote thrombus formation in vivo in a tissue factor‐dependent manner , 2003, Journal of thrombosis and haemostasis : JTH.

[16]  D. Wagner,et al.  P-selectin and leukocyte microparticles are associated with venous thrombogenesis. , 2003, Journal of vascular surgery.

[17]  T. Wakefield,et al.  Neutropenia impairs venous thrombosis resolution in the rat. , 2003, Journal of vascular surgery.

[18]  R. Bucek,et al.  The role of soluble cell adhesion molecules in patients with suspected deep vein thrombosis , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[19]  T. Wakefield,et al.  P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. , 2003, Surgery.

[20]  A. Hafezi-Moghadam,et al.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A , 2003, Nature Medicine.

[21]  R. White,et al.  The epidemiology of venous thromboembolism. , 2003, Circulation.

[22]  J. Chou,et al.  Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.

[23]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[24]  L. Greenfield,et al.  Factors associated with recurrent venous thromboembolism in patients with malignant disease. , 2003, Journal of vascular surgery.

[25]  J. Fallon,et al.  Inhibition of tissue factor limits the growth of venous thrombus in the rabbit , 2003, Journal of thrombosis and haemostasis : JTH.

[26]  Alberto Smith,et al.  Failure of Thrombus to Resolve in Urokinase-Type Plasminogen Activator Gene-Knockout Mice: Rescue by Normal Bone Marrow-Derived Cells , 2003, Circulation.

[27]  Alberto Smith,et al.  Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation , 2003, Thrombosis and Haemostasis.

[28]  J. Fowlkes,et al.  Decrease in fibrin content of venous thrombi in selectin-deficient mice. , 2003, The Journal of surgical research.

[29]  R. Strieter,et al.  Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. , 2002, The Journal of surgical research.

[30]  L. Greenfield,et al.  P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. , 2002, Journal of vascular surgery.

[31]  F. Dignat-George,et al.  Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. , 2002, Blood.

[32]  Chung-Ren Lin,et al.  Early diagnosis of deep vein thrombosis in female patients who undergo total knee arthroplasty with measurement of P-selectin activation. , 2002, Journal of vascular surgery.

[33]  L. Greenfield,et al.  New and Effective Treatment of Experimentally Induced Venous Thrombosis with Anti-inflammatory rPSGL-Ig , 2002, Thrombosis and Haemostasis.

[34]  T. Shimazu,et al.  Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. , 2002, The Journal of trauma.

[35]  Z. Galis,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[36]  S. Rennard,et al.  Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation. , 2001, The Journal of allergy and clinical immunology.

[37]  F. Picard,et al.  Flow Cytometry Detection of Platelet Procoagulant Activity and Microparticles in Patients with Unstable Angina Treated by Percutaneous Coronary Angioplasty and Stent Implantation , 2001, Thrombosis and Haemostasis.

[38]  J. Fowlkes,et al.  Interleukin-8 administration enhances venous thrombosis resolution in a rat model. , 2001, The Journal of surgical research.

[39]  L. Melton,et al.  The Epidemiology of Venous Thromboembolism in the Community , 2001, Thrombosis and Haemostasis.

[40]  T. Shimazu,et al.  Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. , 2001, The Journal of trauma.

[41]  B. Bennett,et al.  Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u‐PA‐dependent mechanism , 2001, British journal of haematology.

[42]  C. Hack,et al.  Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation , 2001, Thrombosis and Haemostasis.

[43]  M. Goebeler,et al.  Chemokines in cutaneous wound healing , 2001, Journal of leukocyte biology.

[44]  L. Greenfield,et al.  P-Selectin Antagonism Causes Dose-dependent Venous Thrombosis Inhibition , 2001, Thrombosis and Haemostasis.

[45]  D. Wagner,et al.  Pro-coagulant state resulting from high levels of soluble P-selectin in blood. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Koksch,et al.  P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[47]  Z. Stelmasiak,et al.  [Blood platelet activation markers in patients with acute cerebral infarction during the earliest stage of the disease--evaluation using flow cytometry methods]. , 2000, Neurologia i neurochirurgia polska.

[48]  J. Badimón,et al.  Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. , 2000, Blood.

[49]  K. Schrör,et al.  Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. , 2000, Thrombosis research.

[50]  J. Hartwig,et al.  P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Expressed on Platelets and Can Mediate Platelet–Endothelial Interactions in Vivo , 2000, The Journal of experimental medicine.

[51]  R. Strieter,et al.  Viral IL-10 Gene Transfer Decreases Inflammation and Cell Adhesion Molecule Expression in a Rat Model of Venous Thrombosis1 2 , 2000, The Journal of Immunology.

[52]  M. U. Nollert,et al.  Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. , 2000, Blood.

[53]  L. Greenfield,et al.  Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. , 2000, Journal of vascular surgery.

[54]  F. Rosendaal,et al.  Increased soluble P‐selectin levels following deep venous thrombosis: cause or effect? , 2000, British journal of haematology.

[55]  K. Burnand,et al.  Changes in the Levels of Soluble Adhesion Molecules and Coagulation Factors in Patients with Deep Vein Thrombosis , 1999, Thrombosis and Haemostasis.

[56]  M. Waltham,et al.  Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. , 1999, Journal of vascular surgery.

[57]  M. Mesri,et al.  Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[58]  K. Peterson,et al.  Acute pulmonary thromboembolism: has its evolution been redefined? , 1999, Circulation.

[59]  M. Prins,et al.  Deep-vein thrombosis , 1999, The Lancet.

[60]  A. M. Lefer,et al.  Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. , 1999, Cardiovascular research.

[61]  G. Raskob,et al.  The Economic Impact of Treating Deep Vein Thrombosis with Low-Molecular-Weight Heparin: Outcome of Therapy and Health Economy Aspects , 1998, Pathophysiology of Haemostasis and Thrombosis.

[62]  M. Mesri,et al.  Endothelial cell activation by leukocyte microparticles. , 1998, Journal of immunology.

[63]  A. M. Lefer,et al.  Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. , 1998, Circulation.

[64]  L. Greenfield,et al.  IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. , 1998, Journal of immunology.

[65]  S. Werner,et al.  Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. , 1998, Experimental cell research.

[66]  K. See-Tho,et al.  Thrombosis with outflow obstruction delays thrombolysis and results in chronic wall thickening of rat veins. , 1998, Journal of vascular surgery.

[67]  G. FitzGerald,et al.  Modulation of monocyte-endothelial cell interactions by platelet microparticles. , 1998, The Journal of clinical investigation.

[68]  J. Douketis,et al.  Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. , 1998, JAMA.

[69]  S. Kunkel,et al.  Novel roles for chemokines and fibroblasts in interstitial fibrosis. , 1998, Kidney international.

[70]  R. Cummings,et al.  Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. , 1997, The Journal of clinical investigation.

[71]  K. Nadeau,et al.  The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. , 1997, The Journal of clinical investigation.

[72]  J. Hirsh,et al.  Management of anticoagulation before and after elective surgery. , 1997, The New England journal of medicine.

[73]  L. Greenfield,et al.  Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. , 1997, Journal of vascular surgery.

[74]  M. Moia,et al.  Subcutaneous Recombinant Hirudin (HBW 023) Versus Intravenous Sodium Heparin in Treatment of Established Acute Deep Vein Thrombosis of the Legs: a Multicentre Prospective Dose-ranging Randomized Trial , 1997, Thrombosis and Haemostasis.

[75]  K S Sakariassen,et al.  Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[76]  Paolo Prandoni,et al.  The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.

[77]  L. Horstman,et al.  Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses. , 1995, Thrombosis research.

[78]  P. Daly,et al.  Elevated platelet-derived microparticle levels during unstable angina. , 1995, The Canadian journal of cardiology.

[79]  L. Wakefield,et al.  Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin , 1995, Nature Medicine.

[80]  L. Greenfield,et al.  Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[81]  M. Sakon,et al.  Quantitative determination of circulating platelet microparticles by flow cytometry. , 1994, International journal of cardiology.

[82]  G. Stewart,et al.  Neutrophils and deep venous thrombosis. , 1993, Haemostasis.

[83]  C. Benjamin,et al.  Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets , 1992, Nature.

[84]  P. Walker,et al.  A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Anderson FA, Wheeler HB, Goldberg RJ, et al. Arch Intern Med 1991;151:933-8 , 1992 .

[85]  D. Hosmer,et al.  A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. , 1991, Archives of internal medicine.

[86]  J. Hirsh Drug therapy : heparin , 1991 .

[87]  S. Weiss Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[88]  U. Albrechtsson,et al.  NEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS , 1985, The Lancet.

[89]  F. Grinnell Fibronectin and wound healing , 1984, Journal of cellular biochemistry.

[90]  M Gent,et al.  Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. , 1979, The New England journal of medicine.

[91]  C. Bacon,et al.  SUCCESSFUL PREGNANCY IN ACUTE LEUKÆMIA , 1975, The Lancet.

[92]  J. Keller,et al.  Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health Study , 1973, Circulation.